HCAT - Health Catalyst - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HCAT is currently covered by 14 analysts with an average price target of $8.12. This is a potential upside of $3.94 (94.26%) from yesterday's end of day stock price of $4.18.

Health Catalyst's activity chart (see below) currently has 149 price targets and 150 ratings on display. The stock rating distribution of HCAT is 30.77% HOLD and 69.23% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.61% with an average time for these price targets to be met of 96.39 days.

Highest price target for HCAT is $16, Lowest price target is $4, average price target is $9.46.

Most recent stock forecast was given by DANIEL GROSSLIGHT from CITI on 25-Apr-2025. First documented stock forecast 19-Aug-2019.

Currently out of the existing stock ratings of HCAT, 16 are a HOLD (30.77%), 36 are a BUY (69.23%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6.5

$2.31 (55.13%)

$10

13 days ago
(25-Apr-2025)

3/11 (27.27%)

$2.4 (58.54%)

269

Buy

$5

$0.81 (19.33%)

$9

22 days ago
(16-Apr-2025)

0/4 (0%)

$1.25 (33.33%)

Buy

$4

$-0.19 (-4.53%)

$10

29 days ago
(09-Apr-2025)

5/9 (55.56%)

$-0.02 (-0.50%)

56

Hold

$6

$1.81 (43.20%)

$7

2 months 11 days ago
(27-Feb-2025)

8/15 (53.33%)

$1.06 (21.46%)

42

Hold

$5

$0.81 (19.33%)

$10

2 months 11 days ago
(27-Feb-2025)

3/9 (33.33%)

$0.06 (1.21%)

57

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HCAT (Health Catalyst) average time for price targets to be met?

On average it took 96.39 days on average for the stock forecasts to be realized with a an average price target met ratio 33.61

Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?

STEVEN HALPER

Which analyst has the most public recommendations on HCAT (Health Catalyst)?

Steven Halper has 9 price targets and 6 ratings on HCAT

Which analyst is the currently most bullish on HCAT (Health Catalyst)?

Sandy Draper with highest potential upside - $50.22

Which analyst is the currently most reserved on HCAT (Health Catalyst)?

Elizabeth Anderson with lowest potential downside - -$0.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?